GPT Healthcare commissions new greenfield quaternary care hospital in Raipur

RPG Life Sciences posts Q4 FY25 net profit at Rs. 117.35 Cr

RPG Life Sciences has reported total income of Rs. 148.15 crores during the period ended March 31, 2025

Thyrocare launches diagnostic lab in Bhagalpur

30th Lab in Thyrocare’s expanding network to bring advanced, affordable diagnostics in Bihar and beyond

Alembic receives USFDA final approval for Ticagrelor Tablets, 90 mg and tentative approval for Ticagrelor Tablets, 60 mg

Ticagrelor tablets are indicated for to reduce the risk of cardiovascular death and myocardial infarction,

USFDA inspection at Concord Biotech’s API facility at Dholka

These observations are procedural in nature and none of them are related to data integrity

Vanta Bioscience receives GLP compliance re-certification

This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility

Zydus Lifesciences completes 25 years of listing on NSE

Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores

SMS Pharmaceuticals’ Vizag plant receives WHO Geneva prequalification

This significant milestone enhances our global regulatory standing

Sanofi Consumer Healthcare India Q1 PAT up 12.9%

The Q1 2025 also witnessed a successful launch of Allegra D

Zydus receives final approval from USFDA for Niacin Extended-Release Tablets USP

Niacin is indicated to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides (TG)